Advanced cytoreductive surgery program development: Building a cytoreductive team Book Section

  


Authors: Zivanovic, O.; Chi, D. S.; Karlan, B. Y.
Editors: Bristow, R. E.; Karlan, B. Y.; Chi, D. S.
Article/Chapter Title: Advanced cytoreductive surgery program development: Building a cytoreductive team
Abstract: RESIDUAL DISEASE Residual disease is defined as the maximum diameter of the largest tumor mass remaining after cytoreductive surgery. The term optimal residual disease has been a shrinking target over the last three decades, with variably defined cutoff values of 3 to 0 cm. © 2010 Informa Healthcare, except as otherwise indicated.
Book Title: Surgery for Ovarian Cancer: Principles and Practice. 2nd ed
ISBN: 9781841847061
Publisher: Informa Healthcare  
Publication Place: New York, NY
Date Published: 2010-01-01
Start Page: 291
End Page: 299
Language: English
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056041480&doi=10.3109%2f9781841847825&partnerID=40&md5=918654483311a1bba40694054c1a7eb1
Notes: Book Chapter: 15 -- Export Date: 3 December 2018 -- Source: Scopus